Home › Funds › Arrowstreet Capital › AMN
Arrowstreet Capital position in AMN
AMN HEALTHCARE SVCS INC · Consumer Discretionary
Latest position (Q2 2026)1.39M sh
Reported value held$45.05M
Portfolio Weight0.02%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 239.30K | $27.46M | New |
| Q4 2021 | 82.23K | $10.06M | Reduce |
| Q1 2023 | 3.79K | $314 | New |
| Q1 2025 | 272.05K | $6.65M | New |
| Q2 2025 | 257.97K | $5.33M | Reduce |
| Q3 2025 | 134.25K | $2.60M | Reduce |
| Q4 2025 | 101.72K | $1.60M | Reduce |
| Q1 2026 | 1.40M | $25.71M | Add |
| Q2 2026 | 1.39M | $45.05M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding AMN
- BlackRock Inc 6.64M sh · $215.05M · Q2 2026
- Morgan Stanley 2.28M sh · $73.89M · Q2 2026
- Vanguard Group 3.63M sh · $57.29M · Q4 2025
- Two Sigma Investments 1.16M sh · $37.49M · Q2 2026
- Royce & Associates 1.15M sh · $37.20M · Q2 2026
- Renaissance Technologies 1.10M sh · $35.49M · Q2 2026
- Goldman Sachs Group 1.05M sh · $33.85M · Q2 2026
- Geode Capital Management 1.01M sh · $32.58M · Q2 2026
- Charles Schwab Investment Management 740.47K sh · $23.97M · Q2 2026
- UBS Group AG 646.55K sh · $20.93M · Q2 2026
- D. E. Shaw & Co 550.64K sh · $17.82M · Q2 2026